sj-docx-2-tah-10.1177_20406207241237607 – Supplemental material for A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis

Kong, Tim; Gaudin, Nicole; Gordon, Karyn; Cox, Maggie J.; Zhou, Amy W.; Oh, Stephen T.

doi:10.25384/SAGE.25404258.v1

sj-docx-2-tah-10.1177_20406207241237607.docx (25.66 kB)

sj-docx-2-tah-10.1177_20406207241237607 – Supplemental material for A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis

journal contribution

posted on 2024-03-14, 00:06 authored by Tim Kong, Nicole Gaudin, Karyn Gordon, Maggie J. Cox, Amy W. Zhou, Stephen T. Oh

Supplemental material, sj-docx-2-tah-10.1177_20406207241237607 for A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis by Tim Kong, Nicole Gaudin, Karyn Gordon, Maggie J. Cox, Amy W. Zhou and Stephen T. Oh in Therapeutic Advances in Hematology